Predicting Stereotactic Body Radiation Therapy Response Using an AI-Based Tumor Vessel Biomarker.

Technol Cancer Res Treat · 2026 · PMC12953968 · PMID 41761492

Europe PMC DOI

hedged sentences

0.0770

closest p · 1.5× alpha

0.0870

boldest claim

The sentences

approached significancep = 0.077so close (0.05 < p ≤ 0.1)

VRS also approached significance in the OS analysis (p = 0.077) and demonstrated excellent predictive power with AUROC of 0.69 (95% CI: 0.61-0.77, p = 0.0001) as a single variable for treatment response prediction.

also in 8,237 other papers

showed a trendp = 0.087so close (0.05 < p ≤ 0.1)

For OS, while not reaching statistical significance, VRS showed a trend toward association with survival outcomes in univariate analysis (HR = 2.50, 95% CI: 0.87-7.12, p = 0.087) ( Table 3 ).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.